For more information about products within the Pathway Portfolio, please click here for prescribing information
The Pathway Portfolio is Aspire Pharma’s branded generic portfolio with products covering a wide range of therapy areas, including: CNS, Respiratory, Cardiovascular, Pain and Urology.
Each product in the portfolio has its own key offerings, ranging from:
- A full range of strengths available1
- A first strength to market1
- Simpler dosing which may help some patients with concordance and compliance1-2
- The first brand to market1
Pathway to Partnership:
Trusted Brands:
- Bioequivalent to brand originators3
- Available from mainline wholesalers
Bespoke Support:
- Price guarantee
- Individualised rebates on request
Our Pathway Portfolio offers a wide range of product support resources, for both healthcare professionals and patients, across a variety of therapeutic areas.
Explore the portfolio
Central Nervous System
Respiratory
Urology
Cardiology
Pain
Learn more about how the Pathway Portfolio can offer your ICB savings
References:
- UK Drug Tariff (accessed October 2024)
- Kyoko Higashiet al. Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis. Neuropsychiatric Disease and Treatment, 2013; 9: 119–131 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552550/
- Data on file, 1010067149 v6.0 September 2023 Bioequivalence data
XLW1010311B2_OCT2024
